LPL Financial
PRME icon

LPL Financial’s Prime Medicine PRME Stock Holding History

LPL Financial’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$24.7K – 5952
2025
Q2 		$24.7K Hold
10,000
– – ﹤0.01% 5443
2025
Q1 		$19.9K Buy
+10,000
New +$25.5K ﹤0.01% 5255

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

LPL Financial's PRME Position: Q1 2026 in Review

LPL Financial increased its Prime Medicine (PRME) stake by 102% in Q1 2026, buying an estimated $128K and bringing the position to 66,424 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #5389.

LPL Financial first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • LPL Financial held 66,424 shares of Prime Medicine worth $231K as of Q1 2026.
  • LPL Financial bought 33,500 Prime Medicine shares in Q1 2026, an estimated $128K.
  • Prime Medicine made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5389 holding.
  • LPL Financial first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.